Portfolio Holdings Detail for ISIN IE0003WV2ME7

Stock Name / Fund	iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)
Issuer	Blackrock
Entity holding fund	iShares III Public Limited Company
Entity Type
Entity LEI	549300PZLRJB7M8H1057
ETF Ticker	ISPE(GBP) LSE
ETF Ticker	ISPE.L(GBP) LSE

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc) MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-09-18 (Thursday)	108,516	USD 8,847,309	USD 8,847,309	128	USD 52,707	USD 81.53	USD 81.14
2025-09-17 (Wednesday)	108,388	USD 8,794,602	USD 8,794,602	0	USD 5,419	USD 81.14	USD 81.09
2025-09-16 (Tuesday)	108,388	USD 8,789,183	USD 8,789,183	0	USD 7,587	USD 81.09	USD 81.02
2025-09-15 (Monday)	108,388	USD 8,781,596	USD 8,781,596
2025-09-12 (Friday)	108,388	USD 8,975,610	USD 8,975,610
2025-09-10 (Wednesday)	108,388	USD 9,107,844	USD 9,107,844
2025-09-09 (Tuesday)	108,452	USD 9,176,124	USD 9,176,124
2025-09-08 (Monday)	108,452	USD 9,119,729	USD 9,119,729

Share Trades of MRK by Blackrock for IE0003WV2ME7

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-18	BUY	128			81.530*		89.22
2025-08-18	BUY	118	85.145	84.080	84.187	GBX 9,934	89.33
2025-08-12	SELL	-64	80.940	79.670	79.797	GBX -5,107	89.47 Profit of 619 on sale
2025-07-29	BUY	68	82.890	76.660	77.283	GBX 5,255	89.61
2025-07-23	SELL	-192	84.140	82.410	82.583	GBX -15,856	89.71 Profit of 1,368 on sale
2025-07-22	SELL	-384	81.770	79.870	80.060	GBX -30,743	89.75 Profit of 3,721 on sale
2025-07-21	SELL	-128	80.310	78.950	79.086	GBX -10,123	89.81 Profit of 1,373 on sale
2025-07-15	SELL	-128	84.360	81.300	81.606	GBX -10,446	89.90 Profit of 1,061 on sale
2025-07-14	SELL	-320	84.300	83.110	83.229	GBX -26,633	89.93 Profit of 2,145 on sale
2025-07-11	SELL	-192	84.130	82.260	82.447	GBX -15,830	89.97 Profit of 1,444 on sale
2025-07-10	SELL	-768	85.000	83.170	83.353	GBX -64,015	90.00 Profit of 5,107 on sale
2025-07-09	SELL	-256	84.480	81.890	82.149	GBX -21,030	90.04 Profit of 2,020 on sale
2025-07-08	SELL	-832	82.380	80.350	80.553	GBX -67,020	90.09 Profit of 7,934 on sale
2025-07-03	SELL	-1,088	82.600	80.700	80.890	GBX -88,008	90.25 Profit of 10,185 on sale
2025-07-02	SELL	-197	82.790	81.894	81.983	GBX -16,151	90.30 Profit of 1,638 on sale
2025-06-27	SELL	-3,136	79.540	78.140	78.280	GBX -245,486	90.43 Profit of 38,107 on sale
2025-06-25	BUY	64	80.120	79.160	79.256	GBX 5,072	90.57
2025-06-24	SELL	-2,368	81.460	79.090	79.327	GBX -187,846	90.63 Profit of 26,765 on sale
2025-06-23	SELL	-64	80.220	78.990	79.113	GBX -5,063	90.69 Profit of 741 on sale
2025-06-20	BUY	20,512	79.920	78.600	78.732	GBX 1,614,951	90.77
2025-06-18	SELL	-318	80.310	77.100	77.421	GBX -24,620	90.91 Profit of 4,289 on sale
2025-06-17	SELL	-583	80.700	78.190	78.441	GBX -45,731	90.99 Profit of 7,315 on sale
2025-06-11	SELL	-162	81.680	79.980	80.150	GBX -12,984	91.11 Profit of 1,776 on sale
2025-06-10	SELL	-378	81.880	79.330	79.585	GBX -30,083	91.18 Profit of 4,382 on sale
2025-06-06	SELL	-108	79.490	78.210	78.338	GBX -8,461	91.33 Profit of 1,404 on sale
2025-06-05	SELL	-918	78.550	77.250	77.380	GBX -71,035	91.42 Profit of 12,892 on sale
2025-06-02	SELL	-4,293			76.250*		91.71 Profit of 393,700 on sale
2025-05-30	SELL	-954			76.840*		91.81 Profit of 87,584 on sale
2025-05-29	SELL	-106			76.400*		91.91 Profit of 9,743 on sale
2025-05-27	SELL	-106	78.200	77.050	77.165	GBX -8,179	92.12 Profit of 1,585 on sale
2025-05-23	SELL	-159			77.580*		92.32 Profit of 14,679 on sale
2025-05-16	SELL	-795	76.165	74.368	74.547	GBX -59,265	92.86 Profit of 14,560 on sale
2025-05-15	SELL	-159			74.800*		92.99 Profit of 14,786 on sale
2025-05-13	SELL	-53			76.630*		93.26 Profit of 4,943 on sale
2025-05-12	SELL	-371			80.430*		93.35 Profit of 34,634 on sale
2025-05-09	SELL	-318			75.970*		93.48 Profit of 29,727 on sale
2025-05-08	SELL	-1,537			77.650*		93.60 Profit of 143,864 on sale
2025-05-07	SELL	-106			79.120*		93.71 Profit of 9,933 on sale
2025-05-06	BUY	40			79.040*		93.82
2025-05-01	BUY	2,014	84.575	83.170	83.310	GBX 167,787	94.07
2025-04-30	BUY	1,113	85.830	83.790	83.994	GBX 93,485	94.14
2025-04-29	SELL	-212	85.690	82.750	83.044	GBX -17,605	94.22 Profit of 2,369 on sale
2025-04-28	SELL	-265	83.680	82.400	82.528	GBX -21,870	94.31 Profit of 3,121 on sale
2025-04-25	BUY	106	83.280	78.060	78.582	GBX 8,330	94.40
2025-04-24	SELL	-53	79.970	76.030	76.424	GBX -4,050	94.52 Profit of 959 on sale
2025-04-22	SELL	-7,102	79.035	77.660	77.798	GBX -552,518	94.78 Profit of 120,592 on sale
2025-04-17	SELL	-3,233	78.746	76.880	77.067	GBX -249,156	95.21 Profit of 58,643 on sale
2025-04-17	SELL	-3,233	78.746	76.880	77.067	GBX -249,156	95.21 Profit of 58,643 on sale
2025-04-16	BUY	106	78.690	75.930	76.206	GBX 8,078	95.37
2025-04-15	BUY	106	79.960	77.720	77.944	GBX 8,262	95.51
2025-04-10	SELL	-3,339	81.120	75.962	76.477	GBX -255,358	95.96 Profit of 65,052 on sale
2025-04-09	BUY	265	81.990	76.000	76.599	GBX 20,299	96.09
2025-04-08	BUY	53	83.270	77.540	78.113	GBX 4,140	96.24
2025-04-07	BUY	954	83.210	79.300	79.691	GBX 76,025	96.38
2025-04-04	BUY	583	86.260	81.090	81.607	GBX 47,577	96.51
2025-04-02	BUY	371			86.600*		96.61
2025-04-01	BUY	4,109			87.120*		96.69
2025-03-31	BUY	3,225			89.760*		96.76
2025-03-25	BUY	52			87.870*		97.09
2025-03-20	BUY	104			94.730*		97.21
2025-03-18	BUY	260			94.720*		97.27
2025-03-17	BUY	32			94.790*		97.29
2025-03-14	SELL	-20			94.570*		97.32 Profit of 1,946 on sale
2025-03-13	SELL	-3,380			94.710*		97.35 Profit of 329,037 on sale
2025-03-12	BUY	624			93.350*		97.39
2025-03-11	BUY	624			94.730*		97.42
2025-03-07	BUY	208			94.650*		97.48
2025-03-06	BUY	728			94.000*		97.51
2025-03-05	BUY	3,952			93.190*		97.56
2025-03-04	BUY	208			92.560*		97.62
2025-03-03	BUY	260	92.790	91.810	91.908	GBX 23,896	97.67
2025-02-28	BUY	520	92.350	90.710	90.874	GBX 47,254	97.74
2025-02-27	BUY	468	90.970	89.250	89.422	GBX 41,849	97.82
2025-02-26	SELL	-275	91.370	88.860	89.111	GBX -24,506	97.92 Profit of 2,423 on sale
2025-02-25	SELL	-52	93.060	90.440	90.702	GBX -4,717	98.00 Profit of 380 on sale
2025-02-24	BUY	52	91.850	88.930	89.222	GBX 4,640	98.09
2025-02-20	SELL	-676	87.700	85.900	86.080	GBX -58,190	98.33 Profit of 8,278 on sale
2025-02-19	BUY	208	85.630	82.850	83.128	GBX 17,291	98.49
2025-02-18	BUY	212	83.590	81.040	81.295	GBX 17,235	98.69
2025-02-13	BUY	5,928	85.690	84.310	84.448	GBX 500,608	99.30
2025-02-12	BUY	1,768	86.670	85.610	85.716	GBX 151,546	99.49
2025-02-11	BUY	1,461	86.990	85.730	85.856	GBX 125,436	99.67
2025-02-07	BUY	156	88.600	87.120	87.268	GBX 13,614	100.04
2025-02-06	BUY	2,080	89.571	87.840	88.013	GBX 183,067	100.21
2025-02-05	BUY	1,040	90.740	87.995	88.270	GBX 91,800	100.37
2025-02-04	BUY	780	91.230	87.330	87.720	GBX 68,422	100.51
2025-02-03	SELL	-4,524	100.145	98.000	98.214	GBX -444,322	100.52 Profit of 10,429 on sale
2025-01-31	BUY	416	100.060	98.580	98.728	GBX 41,071	100.55
2025-01-30	BUY	52	99.410	98.230	98.348	GBX 5,114	100.57
2025-01-29	BUY	884	99.150	97.390	97.566	GBX 86,248	100.61
2025-01-28	BUY	312	98.880	96.590	96.819	GBX 30,208	100.66
2025-01-27	BUY	312	98.620	95.990	96.253	GBX 30,031	100.70
2025-01-24	BUY	312	97.100	95.410	95.579	GBX 29,821	100.79
2025-01-23	BUY	884	97.155	95.230	95.423	GBX 84,353	100.86
2025-01-22	BUY	520	97.000	95.150	95.335	GBX 49,574	100.95
2025-01-21	BUY	3,068	98.270	95.760	96.011	GBX 294,562	101.03
2025-01-17	BUY	624	100.430	97.920	98.171	GBX 61,259	101.14
2025-01-15	BUY	312	100.820	99.618	99.738	GBX 31,118	101.17
2025-01-13	BUY	884	101.159	98.990	99.207	GBX 87,699	101.21
2025-01-10	BUY	676	100.405	98.810	98.969	GBX 66,903	101.25
2024-12-31	BUY	156	99.530	98.434	98.544	GBX 15,373	101.39
2024-12-31	BUY	156	99.530	98.434	98.544	GBX 15,373	101.39
2024-12-30	BUY	208	99.570	98.270	98.400	GBX 20,467	101.46
2024-12-27	BUY	1,002	100.350	99.246	99.356	GBX 99,555	101.50
2024-12-23	BUY	312	99.590	98.201	98.340	GBX 30,682	101.64
2024-12-20	BUY	15,865	99.671	97.900	98.077	GBX 1,555,993	101.73
2024-12-19	BUY	516	99.935	97.820	98.031	GBX 50,584	101.78
2024-12-17	BUY	395	100.800	99.360	99.504	GBX 39,304	101.92
2024-12-16	BUY	129	102.275	100.050	100.273	GBX 12,935	101.98
2024-12-13	BUY	215	102.570	100.530	100.734	GBX 21,658	101.97
2024-12-11	BUY	129			99.750*		102.04
2024-12-10	BUY	86	103.770	100.750	101.052	GBX 8,690	102.07
2024-12-09	BUY	86	105.070	102.330	102.604	GBX 8,824	102.02
2024-12-05	SELL	-258	104.140	101.350	101.629	GBX -26,220	101.93 Profit of 78 on sale
2024-12-04	BUY	45	102.090	101.050	101.154	GBX 4,552	101.95
2024-12-02	BUY	172	101.850	100.460	100.599	GBX 17,303	102.00
2024-11-29	BUY	774	103.040	101.530	101.681	GBX 78,701	102.02
2024-11-27	BUY	172	103.450	101.640	101.821	GBX 17,513	101.93
2024-11-26	BUY	430	101.800	99.700	99.910	GBX 42,961	101.94
2024-11-25	BUY	5,332	101.740	99.510	99.733	GBX 531,776	101.97
2024-11-22	BUY	129	101.790	98.930	99.216	GBX 12,799	102.11
2024-11-21	BUY	129	100.480	96.950	97.303	GBX 12,552	102.22
2024-11-20	BUY	559	98.840	96.660	96.878	GBX 54,155	102.47
2024-11-19	SELL	-559	97.550	95.260	95.489	GBX -53,378	102.80 Profit of 4,087 on sale
2024-11-18	BUY	2,580	97.290	95.420	95.607	GBX 246,666	103.17
2024-11-12	BUY	516	100.760	98.500	98.726	GBX 50,943	103.46
2024-11-11	BUY	129	103.370	100.460	100.751	GBX 12,997	103.64
2024-11-08	BUY	518	103.230	101.020	101.241	GBX 52,443	103.69
2024-11-07	BUY	872	101.690	100.850	100.934	GBX 88,014	103.88
2024-11-06	BUY	387	103.230	100.605	100.868	GBX 39,036	104.14
2024-11-05	BUY	86	101.730	100.520	100.641	GBX 8,655	104.37
2024-11-04	BUY	445	102.530	100.950	101.108	GBX 44,993	104.62
2024-11-01	BUY	215	102.720	101.210	101.361	GBX 21,793	104.93
2024-10-30	BUY	126	105.000	102.900	103.110	GBX 12,992	105.31
2024-10-29	BUY	798	105.110	103.700	103.841	GBX 82,865	105.57
2024-10-25	BUY	168	106.490	103.860	104.123	GBX 17,493	106.31
2024-10-24	BUY	126	106.620	105.260	105.396	GBX 13,280	106.45
2024-10-22	BUY	252	106.900	105.710	105.829	GBX 26,669	106.34
2024-10-21	BUY	210	109.170	106.180	106.479	GBX 22,361	0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer